Clinical trial
Study of DS-5141b in Patients With Duchenne Muscular Dystrophy
NCT02667483 · Daiichi Sankyo Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT02667483 |
|---|---|
| Title | Study of DS-5141b in Patients With Duchenne Muscular Dystrophy |
| Official title | Phase I/II Study of DS-5141b: Open-label Study of DS-5141b in Patients With Duchenne Muscular Dystrophy |
| Lead sponsor | Daiichi Sankyo Co., Ltd., Industry |
| Collaborators | Daiichi Sankyo Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Duchenne Muscular Dystrophy |
| Intervention type | Drug |
| Interventions | DS-5141b |
| Enrollment | 8 |
| Start date | Oct 1, 2015 |
| Primary completion | Oct 20, 2020 |
| Completion | Oct 20, 2020 |
| First posted | Jan 29, 2016 |
| Last update posted | Mar 7, 2024 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: